OPTH

Optimi Health Corp.
CAPPED RATING

Optimi Health Corp. (OPTH) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (C+); its weakest is Momentum (D-). The rating has held at C for 7 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
C+
Factor Score 2.5 / 5.0
Growth
C+
Factor Score 2.7 / 5.0
Profitability
C
Factor Score 2.3 / 5.0
Momentum
D-
Factor Score 1.1 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -1.2
Rev Growth YoY -28.6%
Gross Margin N/M
Price Return 3M -52.8%
Price Return 12M -63.0%
Catalyst Signal 0.00
Market Cap $12.9M
TTM Revenue $175.7K
Price / Sales 73.3
ROE -54.4%

Historical Factor Score Progression

Held C for 7 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 C+ (2.5) C+ (2.7) C (2.3) D- (1.1) C+ (2.6) C (2.3)
2026-11-07 C+ (2.5) C+ (2.7) C (2.3) D (1.4) C+ (2.7) C (2.3)
2026-10-31 C+ (2.5) C+ (2.7) C (2.3) D+ (1.6) C+ (2.7) C (2.3)
2026-10-24 C (2.3) C+ (2.7) C (2.3) D+ (1.8) C+ (2.6) C (2.3)
2026-10-17 C (2.3) C+ (2.7) C (2.3) C- (1.9) C+ (2.6) C (2.4)
Page 1 of 4